- Filed
- Jul 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 16, 2025 | 46.89M sh |
| Shares Diluted | Q2 2025 · Jun 29, 2025 | 47.4M sh |
| Shares Diluted | Q2 2025 · Jun 29, 2025 | 47.4M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 47.8M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 47.9M sh |
| Stock Repurchased | Q2 2025 · Jun 29, 2025 | $2.9M |
| Stock Repurchased | Q2 2025 · Jun 30, 2024 | $193.8M |
| Capex | Q2 2025 · Jun 29, 2025 | $48.3M |
| Capex | Q2 2025 · Jun 30, 2024 | $33.6M |
| Operating Cash Flow | Q2 2025 · Jun 29, 2025 | $469.2M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $609.7M |
| Long Term Debt | Q2 2025 · Jun 29, 2025 | $2.17B |
| Long Term Debt | Q2 2025 · Dec 29, 2024 | $2.65B |
| Short Term Debt | Q2 2025 · Jun 29, 2025 | $450.2M |
| Short Term Debt | Q2 2025 · Dec 29, 2024 | $300K |
| Cash And Equivalents | Q2 2025 · Jun 29, 2025 | $310.9M |
| Cash And Equivalents | Q2 2025 · Dec 29, 2024 | $649.8M |
| Stockholders Equity | Q2 2025 · Jun 29, 2025 | $10.38B |
| Stockholders Equity | Q2 2025 · Mar 30, 2025 | $9.93B |
| Stockholders Equity | Q2 2025 · Dec 29, 2024 | $9.55B |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $9.32B |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $9.33B |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $9.22B |
| Current Liabilities | Q2 2025 · Jun 29, 2025 | $1.76B |
| Current Liabilities | Q2 2025 · Dec 29, 2024 | $1.26B |
| Total Liabilities | Q2 2025 · Jun 29, 2025 | $4.75B |
| Total Liabilities | Q2 2025 · Dec 29, 2024 | $4.65B |
| Current Assets | Q2 2025 · Jun 29, 2025 | $2.92B |
| Current Assets | Q2 2025 · Dec 29, 2024 | $2.94B |
| Total Assets | Q2 2025 · Jun 29, 2025 | $15.14B |
| Total Assets | Q2 2025 · Dec 29, 2024 | $14.2B |
| Eps Diluted | Q2 2025 · Jun 29, 2025 | $4.43 |
| Eps Diluted | Q2 2025 · Jun 29, 2025 | $8.41 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $3.77 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | $7.49 |
| Eps Basic | Q2 2025 · Jun 29, 2025 | $4.48 |
| Eps Basic | Q2 2025 · Jun 29, 2025 | $8.51 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $3.82 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | $7.58 |
| Sga Expense | Q2 2025 · Jun 29, 2025 | $229.4M |
| Sga Expense | Q2 2025 · Jun 29, 2025 | $463.3M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $224.8M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $444.5M |
| Rd Expense | Q2 2025 · Jun 29, 2025 | $82.4M |
| Rd Expense | Q2 2025 · Jun 29, 2025 | $156.7M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $71.7M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $148.2M |
| Net Income | Q2 2025 · Jun 29, 2025 | $209.9M |
| Net Income | Q2 2025 · Jun 29, 2025 | $398.5M |
| Net Income | Q2 2025 · Mar 30, 2025 | $188.6M |
| Net Income | Q2 2025 · Jun 30, 2024 | $180.2M |
| Net Income | Q2 2025 · Jun 30, 2024 | $358.7M |
| Net Income | Q2 2025 · Mar 31, 2024 | $178.5M |
| Operating Income | Q2 2025 · Jun 29, 2025 | $278.2M |
| Operating Income | Q2 2025 · Jun 29, 2025 | $537.5M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $247M |
| Operating Income | Q2 2025 · Jun 30, 2024 | $481.3M |
| Cost Of Revenue | Q2 2025 · Jun 29, 2025 | $869.1M |
| Cost Of Revenue | Q2 2025 · Jun 29, 2025 | $1.7B |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $781.5M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $1.55B |
| Revenue | Q2 2025 · Jun 29, 2025 | $1.51B |
| Revenue | Q2 2025 · Jun 29, 2025 | $2.96B |
| Revenue | Q2 2025 · Jun 30, 2024 | $1.37B |
| Revenue | Q2 2025 · Jun 30, 2024 | $2.72B |